Powder: -20°C for 3 years | In solvent: -80°C for 1 year
13,14-dihydro-15-keto Prostaglandin E1 inhibits ADP-induced platelet aggregation in human isolated platelet-rich plasma (IC50=14.8 μg/mL) and is a PGE1 metabolite.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 77.00 | |
5 mg | Inquiry | $ 357.00 | |
10 mg | Inquiry | $ 636.00 |
Description | 13,14-dihydro-15-keto Prostaglandin E1 inhibits ADP-induced platelet aggregation in human isolated platelet-rich plasma (IC50=14.8 μg/mL) and is a PGE1 metabolite. |
Synonyms | 13,14-dihydro-15-keto Prostaglandin E1 |
Molecular Weight | 354.487 |
Formula | C20H34O5 |
CAS No. | 5094-14-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS (pH 7.2): >1.6 mg/mL (from PGE1)
DMSO: >50 mg/mL (from PGE1)
DMF: >100 mg/mL (from PGE1)
Ethanol: >50 mg/mL (from PGE1)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
13,14-dihydro-15-keto Prostaglandin E1 5094-14-4 13,14 dihydro 15 keto Prostaglandin E1 13,14dihydro15keto Prostaglandin E1 13,14-dihydro-15-keto Prostaglandin E-1 inhibitor inhibit